Aphria Inc APHA:NYSE

Last Price$4.75NYSE Closing Price as of 6:30PM ET 11/12/19

Today's Change-0.22(4.43%)
Bid (Size)$4.71 (5)
Ask (Size)$5.00 (1)
Day Low / High$4.70 - 4.98
Volume4.1 M

Read more news Recent News

Analyst Actions: Cantor Fitzgerald Initiates Coverage on Aphria With Overweight Rating, Sets C$10.40 PT
9:37AM ET 11/05/2019 MT Newswires

Aphria's (APHA) average rating among analysts is a buy, with an average price target of $12. Price: 5.12, Change: -0.01, Percent Change: -0.19 ...

Aphria Receives New Canadian Cannabis License -- Shares Rise 6%
6:41AM ET 11/04/2019 MT Newswires

Aphria (APHA, APHA.TO) rose by nearly 6% in pre-market trading as the cannabis company said it has received a new Canadian cultivation license that will...

Sector Update: Most Leading Health Care Stocks Advance Pre-Market Tuesday
9:20AM ET 10/15/2019 MT Newswires

Top Health Care Stocks: JNJ: +2.01% PFE: +0.14% ABT: Flat MRK: +0.20% AMGN: Flat Leading health care stocks were mostly advancing pre-market Tuesday....

Wall Street Sees Cautiously Higher Open as Q3 Earnings Season Kicks Off
9:13AM ET 10/15/2019 MT Newswires

US stocks were set for a moderately higher open Tuesday as traders digested the first wave of corporate results for the Q3 earnings season. Dow, S&P and...

View all Commentary and Analysis

Weekly Cannabis Report: KushCo And CV Sciences Disappointed
12:24PM ET 11/12/2019 Seeking Alpha

Growing Like A Weed, Trulieve Offers Potential 300% Return In 2020
9:54AM ET 11/06/2019 Seeking Alpha

Growing Pains, With Irwin Simon, CEO, Aphria (Podcast Transcript)
6:08AM ET 11/04/2019 Seeking Alpha

Growing Pains, With Irwin Simon, CEO, Aphria
7:30AM ET 10/30/2019 Seeking Alpha

Company Profile

Business DescriptionAphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. View company web site for more details
Address265 Talbot Street West
Leamington, Ontario N8H 4H3
Number of EmployeesN/A
Chairman & Chief Executive OfficerIrwin David Simon
Chief Operating Officer-Aphria LeamingtonJames R. Meiers
Chief Financial OfficerCarl A. Merton
Chief Information & Information Security OfficerTim Purdie

Company Highlights

Price Open$4.94
Previous Close$4.97
52 Week Range$3.75 - 12.50
Market Capitalization$1.2 B
Shares Outstanding251.6 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement01/10/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.15
Beta vs. S&P 500N/A
Revenue$179.3 M
Net Profit Margin-5.67%
Return on Equity-1.15%

Analyst Ratings as of 11/10/2019

Consensus RecommendationConsensus Icon
Powered by Factset